INTELLIA THERAPEUTICS, INC. (NTLA) Revenue 2016–2025
INTELLIA THERAPEUTICS, INC. (NTLA) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$67.7MFY2025 · since FY2016: $16.5M → $67.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $67.7M | +16.9% |
| FY2024 | $57.9M | +59.6% |
| FY2023 | $36.3M | -30.4% |
| FY2022 | $52.1M | +57.7% |
| FY2021 | $33.1M | -43.0% |
| FY2020 | $58.0M | +34.5% |
| FY2019 | $43.1M | +41.6% |
| FY2018 | $30.4M | +16.5% |
| FY2017 | $26.1M | +58.5% |
| FY2016 | $16.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice